KSKrzysztof Sajewicz

Krzysztof Sajewicz

*This is an algorithmically generated author record based on publicly available information.

Krzysztof Sajewicz has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The impact of physical activity on insomnia, compared to pharmacological interventions: a narrative review

    by Mikołaj Albert Kaczmarek, Wiktoria Grochowska, Krzysztof Sajewicz, Martyna Helwich, Nel Geworkian, Julia Dulęba

    Background: Insomnia is a significant public health concern associated with reduced quality of life and persistent symptoms in many individuals. While cognitive behavioral therapy is the first-line treatment, its high cost limits accessibility, and there is growing interest in non-pharmacological approaches such as physical activity.Material and methods: A comprehensive search was conducted in PubMed, Google Scholar, and the Cochrane Library using predefined keywords to identify observational studies, clinical trials, reviews, systematic reviews, and meta-analyses on physical activity and pharmacotherapy for insomnia. Of the 384 records initially identified, 38 studies meeting the inclusion criteria were included in the final analysis.Results: Physical activity emerges as a promising adjunctive treatment for chronic insomnia, offering moderate improvements in subjective sleep quality without the adverse effects and dependency risks associated with pharmacotherapy.Conclusions: While pharmacological treatments provide rapid symptom relief and improve objective sleep parameters, physical activity offers broader health benefits and may serve as a complementary strategy for long-term insomnia management. Future research directly comparing these approaches should clarify their roles in optimizing treatment strategies for insomnia.

  • Open Access

    Obesity as a Multidisciplinary Challenge

    by Aleksandra Mazur, Krzysztof Sajewicz, Julia Dulęba, Paulina Strzałkowska, Filip Kin, Joanna Koszałko, Monika Kaźmierczak, Maciej Hobot, Julia Kalisiak, Nel Geworkian

    Purpose. Obesity is a chronic metabolic disease that has reached epidemic proportions worldwide, affecting individuals across all ages, genders, and socioeconomic backgrounds. Its growing prevalence presents a significant public health issue due to the various complications it leads to, such as metabolic disorders, cardiovascular diseases, and psychological or social problems. The aim of this article is to analyze the effectiveness of current therapeutic approaches to obesity, with particular focus on dietary interventions, pharmacotherapy, psychotherapy, and surgical treatment. Materials and Methods. This article is based on a literature review of obesity treatment methods. Data from clinical trials, meta-analyses, and clinical guidelines were selected through searches in databases such as PubMed and Google Scholar. Keywords are “obesity”, “diet”, “anti-obesity drugs”, “pharmacotherapy”, “psychotherapy” and “bariatric surgery.” Priority was given to studies published between 2020 and 2025. Findings. This review provides an overview of current obesity treatment strategies. While dietary changes are the key element of treatment, combining them with pharmacotherapy and psychological support enhances effectiveness and leads to better long-term outcomes. Surgical intervention is reserved for severe cases after other methods have been explored. Each approach is assessed for its effectiveness, safety, and role within a comprehensive treatment plan.

  • Open Access

    Polycystic Ovary Syndrome – A Clinical and Psychosocial Perspective

    by Paulina Strzałkowska, Aleksandra Mazur, Julia Dulęba, Krzysztof Sajewicz, Oskar Tudaj, Monika Kaźmierczak, Wiktoria Kalas, Julia Kalisiak, Joanna Koszałko, Filip Kin

    Polycystic Ovary Syndrome (PCOS) is one of the most common endocrinopathies among women of reproductive age, characterized by a complex etiology and diverse clinical presentation. The aim of this paper is to present the current state of knowledge regarding the definition, diagnostic criteria, and differential diagnosis of PCOS, as well as to discuss treatment methods—both non-pharmacological and pharmacological. Particular attention is given to psychological aspects, which are often overlooked in clinical practice, despite their significant impact on the course of the disease and the quality of life of affected women. Women with PCOS more frequently experience depressive and anxiety disorders, along with low self-esteem, which can substantially hinder effective treatment and worsen prognosis. This paper emphasizes the need for a holistic approach to PCOS patients, taking into account not only somatic symptoms but also psychological and emotional needs, as a prerequisite for effective and long-term therapy.

  • Open Access

    IgA Vasculitis – An In-Depth Literature Review

    by Julia Dulęba, Krzysztof Sajewicz, Aleksandra Mazur, Oskar Tudaj, Monika Kaźmierczak, Joanna Koszałko, Filip Kin, Paulina Strzałkowska, Julia Kalisiak, Wiktoria Kalas

    Introduction and Objective: Immunoglobulin A vasculitis (IgAV), previously Henoch-Schönlein purpura, is a systemic leukocytoclastic vasculitis of small vessels, characterised by the deposition of immunoglobulin A complexes in their walls. It represents the most prevalent form of vasculitis in children and may progress to IgA nephropathy, the leading cause of primary glomerulonephritis. This review provides a comprehensive overview of IgAV, covering its epidemiology, pathogenesis, clinical features, diagnosis, treatment, complications, and prognosis. Materials and Methods: A narrative review was conducted, using PubMed articles up to 2024, focusing on recent data. Key sources included clinical guidelines (EULAR/PRINTO/PRES 2010 for paediatrics, ACR 1990 for adults) and contemporary studies on genetic, immunological, and therapeutic aspects. Data were synthesised to compare disease presentation and management in children and adults. Results and Conclusions: IgAV predominantly affects children aged 3–15 years (incidence 3.0–27.0 per 100,000), often triggered by upper respiratory tract infections. In adults, the condition is rarer but more severe. Diagnosis relies on clinical criteria, with biopsy reserved for atypical cases. Treatment is primarily symptomatic, employing glucocorticoids for acute symptoms and immunosuppressive agents for severe cases. Complications, such as gastrointestinal and renal disorders, are more frequent in adults. Prognosis is favourable, with 94% of paediatric cases resolving within two years, although adults are at greater risk of chronic kidney disease and relapses. Early intervention and monitoring are critical for improving outcomes.

  • Open Access

    Pertussis - A Comprehensive Review of Etiology, Diagnosis, Treatment and Prevention

    by Krzysztof Sajewicz, Julia Dulęba`, Paulina Strzałkowska, Monika Kaźmierczak, Oskar Tudaj, Joanna Koszałko, Aleksandra Mazur, Filip Kin, Julia Kalisiak, Wiktoria Kalas

    Introduction and Aim: Whooping cough, caused by Bordetella pertussis, remains a global health challenge despite widespread vaccination. This review summarizes current data on its epidemiology, pathogenesis, and clinical presentation across age groups. Materials and Methods: The review analyzes scientific literature, reports, and guidelines up to June 2025, sourced from PubMed. Search terms included “whooping cough” combined with “epidemiology,” “COVID-19,” “vaccinations,” and “macrolides.” Data underwent qualitative and quantitative analysis for accurate presentation. Results and Conclusions: Poland saw a surge in whooping cough cases post-COVID-19 restrictions, rising from 182 in 2021 to 32,430 in 2024, driven by waning vaccine immunity. Infants face the highest risk, with a mortality rate of up to 1%. Diagnosis relies on PCR, microbiological culture, and serological tests. Macrolides are used for treatment and prophylaxis, reducing transmission if administered early. Acellular vaccines offer effective protection with fewer side effects but require boosters due to shorter immunity duration. Controlling incidence requires maintaining >95% vaccination coverage, targeted antibacterial treatment, and research into new vaccines to address evolving Bordetella pertussis strains.


  • Open Access

    The relationship between rheumatoid arthritis (RA) and psychiatric disorder

    by Monika Kaźmierczak, Oskar Tudaj, Wiktoria Kalas, Krzysztof Sajewicz, Julia Dulęba, Julia Kalisiak, Mikołaj Musiał, Maciej Hobot, Aleksandra Mazur, Filip Kin

    Rheumatoid arthritis (RA) is a chronic autoimmune disease that has a destructive effect on the joints, but also leads to many systemic complications, including mental disorders. This review will present the co-occurrence of mood disorders, such as depression, anxiety and cognitive disorders, in patients with RA and analyze the potential pathophysiological mechanisms. The impact of chronic inflammation and proinflammatory cytokines (IL-6, IL-1β, TNF-α) on the central nervous system and the hypothalamic-pituitary-adrenal axis (HPA) will be discussed. When rheumatoid arthritis (RA) is accompanied by mental health disorders, treatment methods used for RA may be less effective. This can make the condition harder to manage, increasing pain and reducing the quality of life. Additionally, the paper will present the impact of pain, fatigue and reduced physical fitness on the deterioration of the mental health of patients. In addition to the pharmacological treatment used for RA, which is also not neutral to patient’s health, additional therapeutic options such as psychological interventions will be discussed. Considering both somatic and psychological aspects, an interdisciplinary approach to the treatment of patients with RA is very important.


  • Open Access

    Treatment Methods for Knee Osteoarthritis - A Literature Review

    by Oskar Tudaj, Krzysztof Sajewicz, Aleksandra Mazur, Mikołaj Kaczmarek, Wiktoria Grochowska, Adrianna Dylik, Julia Kalisiak, Wiktoria Kalas, Paulina Strzałkowska, Julia Dulęba

    Introduction And objective: Knee osteoarthritis (KOA) is one of the leading causes of disability worldwide. It is associated with pain and a reduced range of joint motion. As this condition affects an increasing number of patients, effective treatment strategies are needed. The aim of the study: This article focuses on presenting the therapeutic methods for knee osteoarthritis. Its aim is to highlight their indications, mechanisms of action and effectiveness. Material and methods: The PubMed database was used to gather information on knee osteoarthritis and its treatment methods. The review primarily focused on systematic reviews, meta-analyses and studies. The most commonly used search terms were 'knee osteoarthritis' and 'knee osteoarthritis treatment'." Summary of current knowledge: Treatment depends on the stage of the disease, the patient’s expectations, and their level of engagement. A wide range of therapeutic options for KOA is available - starting from conservative methods such as physiotherapy, through intra-articular injections and ending with surgical interventions. Many of these techniques can and should be used simultaneously to achieve the most beneficial outcome. Conclusions: Multidisciplinary approach combining various therapeutic methods involving specialists from different fields is often needed to achieve effective treatment. Currently, significant emphasis is being placed on research into cartilage regenerative therapies, which are seen as a promising direction for the future.